期刊文献+

NS-398对结直肠癌细胞HT-29放射增敏机制的初探

Initial Investigation on Mechanisms of Radiosensitization of NS-398 on HT-29 Cell Lines of Colorectal Carcinoma
暂未订购
导出
摘要 目的:探讨COX-2抑制剂NS-398对结直肠癌细胞系HT-29的放射增敏作用及其相关机制。方法:COX-2高表达细胞系HT-29经25μmol/LNS-398处理24h后,给以不同剂量(0、2、4、6、8Gy)X-ray照射,应用克隆形成实验测NS-398对HT-29细胞的放射增敏作用,流式细胞仪(FCM)分析NS-398对HT-29细胞凋亡及细胞周期的影响,RT-PCR和FCM观察NS-398处理后Bax、Bcl-2在mRNA及蛋白水平的表达变化。结果:25μmol/LNS-398对HT-29有明显增敏作用,细胞存活分数(SF)为0.1时,放射增敏比SER为1.76;NS-398诱导HT-29凋亡、增强HT-29对放射诱导凋亡的敏感性,同时抑制细胞增殖;BaxmRNA及蛋白表达呈NS-398剂量依赖性增高,而Bcl-2的表达无明显变化。结论:NS-398对HT-29有放射增敏作用,其机制与诱导凋亡、直接抑制细胞增殖有关。 Objective: To investigate the radiosensitizing effect and mechanisms of COX-2 inhibitor NS-398 on colorectal cancer cell lines HT-29. Methods: Colorectal cancer cell lines HT-29 had been incubated with 25μM NS-398 before X-ray irradiation at: different doses (0, 2, 4, 6 and 8Gy). The cells were assayed for clonogenic survival to determine the radiosensitizing effect of NS-398. Flow cytometry was used to determine the effects of NS-398 and radiation on apoptosis and cell cycle distribution. The changes of mRNA and protein of Bax and Bcl-2 of HT-29 were measured by RT-PCR and flow cytometry after treatment with NS-398. Results: When survival fraction was 0.1, the sensitizationenhancement ratio was 1.76. NS-398 induced apoptosis in HT-29 cells alone and enhanced its sensitivity to irradiation-induced apoptosis. NS-398 also inhibited the proliferation of HT-29 cells. The expression of Bax mRNA and protein were increased after treatment with 25μM NS-398 at a dose-dependent manner, whereas there was no changes with Bcl-2. Conclusion: The findings indicate that the COX-2 inhibitor NS-398 has radiosensitizing effect on HT-29 ceils by induction of the apoptosis and inhibition of the cell proliferation.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2006年第19期1112-1116,共5页 Chinese Journal of Clinical Oncology
基金 山东省自然科学基金资助(编号:Z2005Co2)
关键词 环氧合酶抑制剂 放射增敏 凋亡 NS-398 Cyclooxygenase-2 Inhibitors Radiosensitivity Apoptosis NS-398
  • 相关文献

参考文献1

二级参考文献45

  • 1Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995; 76:1116-1119.
  • 2R~ubio CA. Antitumoral activity of indomethacin on experimental esophageal tumors. J Natl Cancer Inst 1984; 72:705-707.
  • 3Rubio CA. Further studies on the therapeutic effect of indomethacin on esophageal tumors. Cancer 1986; 58:1029-1031.
  • 4Ciaparrone M, Yamamoto H, Yao Y, Sgambato A, Cattoretti G, Tomita N, Monden T, Rotterdam H, Weinstein IB. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. Cancer Res 1998; 58:114-122.
  • 5Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S,Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-1316.
  • 6Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C,Duhamel O, Trousset M, Attali P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101:635-639.
  • 7Tonelli F, Valanzano R. Sulindac in familial adenomatous polyposis. Lancet 1993; 342:1120.
  • 8Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 325:1593-1596.
  • 9Schreinemachers DM, Everson RB. Aspirin use and lung,colon, and breast cancer incidence in a prospective study. Epidemiology 1994, 5:138-146.
  • 10Takahashi M, Furukawa F, Toyoda K, Sato H, Hasegawa R,Imaida K, Hayashi Y. Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis 1990; 11:393-395.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部